US Stock MarketDetailed Quotes

Aytu BioPharma (AYTU)

Watchlist
  • 2.600
  • +0.020+0.78%
Close Apr 17 15:59 ET
  • 2.600
  • 0.0000.00%
Post 16:10 ET
27.91MMarket Cap-0.98P/E (TTM)

Aytu BioPharma (AYTU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
-6.51%15.17M
-16.21%13.89M
1.84%66.38M
3.71%15.14M
31.57%18.45M
-13.48%16.22M
-6.98%16.57M
-39.31%65.18M
-52.52%14.59M
-38.31%14.03M
Operating revenue
-6.51%15.17M
-16.21%13.89M
1.84%66.38M
3.71%15.14M
31.57%18.45M
-13.48%16.22M
-6.98%16.57M
-39.31%65.18M
-52.52%14.59M
-38.31%14.03M
Cost of revenue
1.95%5.54M
2.46%4.7M
27.42%20.55M
37.84%4.88M
54.09%5.65M
31.12%5.44M
-3.98%4.59M
-60.44%16.13M
-70.90%3.54M
-63.32%3.66M
Gross profit
-10.77%9.62M
-23.35%9.19M
-6.57%45.83M
-7.22%10.25M
23.60%12.81M
-26.14%10.79M
-8.08%11.99M
-26.38%49.05M
-40.47%11.05M
-18.69%10.36M
Operating expense
3.85%11.59M
-11.88%10.69M
-10.71%43.29M
-15.76%9.61M
-11.35%10.39M
-2.56%11.16M
-12.76%12.13M
-38.59%48.49M
-27.56%11.41M
-46.84%11.71M
Selling and administrative expenses
13.86%11.07M
-4.99%10.25M
-8.93%38.29M
-10.30%8.48M
-8.64%9.3M
-2.96%9.72M
-12.93%10.78M
-40.01%42.04M
-32.95%9.45M
-49.04%10.18M
-Selling and marketing expense
13.77%6M
-5.96%5.32M
-5.33%20.91M
-11.82%4.78M
-2.95%5.19M
1.03%5.27M
-7.09%5.66M
-46.72%22.08M
-32.07%5.42M
-58.20%5.35M
-General and administrative expense
13.96%5.07M
-3.92%4.92M
-12.90%17.38M
-8.24%3.7M
-14.95%4.11M
-7.31%4.45M
-18.59%5.13M
-30.30%19.95M
-34.11%4.03M
-32.69%4.83M
Research and development costs
--0
--0
-52.11%1.33M
-79.27%216K
-73.49%162K
0.19%522K
-28.40%426K
-32.38%2.77M
124.09%1.04M
-28.62%611K
Depreciation amortization depletion
-42.89%526K
-51.79%444K
0.00%3.68M
0.00%921K
0.00%920K
0.33%921K
-0.32%921K
-23.08%3.68M
-22.93%921K
-23.21%920K
-Depreciation and amortization
-42.89%526K
-51.79%444K
0.00%3.68M
0.00%921K
0.00%920K
0.33%921K
-0.32%921K
-23.08%3.68M
-22.93%921K
-23.21%920K
Operating profit
-421.16%-1.97M
-930.14%-1.5M
349.03%2.54M
277.29%640K
278.94%2.42M
-112.02%-378K
83.16%-146K
104.58%565K
-112.85%-361K
85.44%-1.35M
Net non-operating interest income expense
48.10%-560K
48.09%-516K
26.80%-3.7M
41.74%-730K
28.40%-900K
14.77%-1.08M
22.53%-994K
-1.93%-5.06M
-1.25M
-1.26M
Non-operating interest expense
-48.10%560K
-48.09%516K
-26.80%3.7M
-41.74%730K
-28.40%900K
-14.77%1.08M
-22.53%994K
1.93%5.06M
--1.25M
--1.26M
Other net income (expense)
-537.96%-8.05M
51.06%3.99M
-113.78%-12.58M
-1,996.75%-19.35M
172.48%2.3M
482.33%1.84M
149.56%2.64M
-2,541.49%-5.88M
-204.62%-923K
-59.70%843K
Gain on sale of security
-373.34%-8.24M
31.39%3.78M
57.47%-1.7M
-773.96%-9.86M
122.32%2.26M
622.70%3.02M
148.76%2.88M
-183.54%-4M
206.48%1.46M
-60.47%1.02M
Special income (charges)
--0
--0
-276.87%-10.36M
-229.73%-8.26M
--0
---1.32M
---784K
41.93%-2.75M
5.08%-2.51M
-133.24%-244K
-Less:Restructuring and merger&acquisition
--0
--0
-2.55%2.1M
--0
--0
--1.32M
--784K
322.50%2.16M
511.18%1.91M
133.24%244K
-Less:Impairment of capital assets
----
----
----
----
----
----
----
----
----
--0
-Less:Other special charges
----
----
----
----
----
----
----
--594K
----
----
-Write off
----
----
--8.26M
----
----
----
----
--0
----
----
Other non- operating income (expenses)
35.71%190K
-62.92%201K
-158.85%-512K
-1,125.00%-1.23M
-48.57%36K
45.83%140K
-7.19%542K
372.83%870K
-96.77%120K
105.76%70K
Income before tax
-2,870.68%-10.58M
31.17%1.97M
-32.44%-13.75M
-666.38%-19.44M
316.07%3.82M
-72.69%382K
120.05%1.5M
39.14%-10.38M
-3.26%-2.54M
75.46%-1.77M
Income tax
0
0
-79.60%437K
-48.04%437K
-123.42%-122K
-136.28%-283K
405K
2.14M
841K
521K
Net income
-1,443.15%-10.58M
33.31%1.97M
14.40%-13.56M
-329.24%-19.82M
238.34%3.99M
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
Net income continuous Operations
-1,691.58%-10.58M
79.78%1.97M
-13.27%-14.18M
-488.51%-19.88M
272.20%3.94M
7.43%665K
114.63%1.09M
26.57%-12.52M
-37.48%-3.38M
68.22%-2.29M
Net income discontinuous operations
--0
--0
118.65%620K
105.00%62K
109.02%54K
114.66%123K
158.89%381K
---3.32M
---1.24M
---599K
Minority interest income
Net income attributable to the parent company
-1,443.15%-10.58M
33.31%1.97M
14.40%-13.56M
-329.24%-19.82M
238.34%3.99M
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,443.15%-10.58M
33.31%1.97M
14.40%-13.56M
-329.24%-19.82M
238.34%3.99M
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
Basic earnings per share
-907.69%-1.05
-12.50%0.21
24.48%-2.16
-287.80%-3.18
225.00%0.65
425.00%0.13
116.22%0.24
44.03%-2.86
-38.98%-0.82
73.06%-0.52
Diluted earnings per share
-303.85%-1.05
46.67%-0.08
24.48%-2.16
-287.80%-3.18
140.38%0.21
-550.00%-0.26
89.86%-0.15
44.03%-2.86
-38.98%-0.82
73.06%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue -6.51%15.17M-16.21%13.89M1.84%66.38M3.71%15.14M31.57%18.45M-13.48%16.22M-6.98%16.57M-39.31%65.18M-52.52%14.59M-38.31%14.03M
Operating revenue -6.51%15.17M-16.21%13.89M1.84%66.38M3.71%15.14M31.57%18.45M-13.48%16.22M-6.98%16.57M-39.31%65.18M-52.52%14.59M-38.31%14.03M
Cost of revenue 1.95%5.54M2.46%4.7M27.42%20.55M37.84%4.88M54.09%5.65M31.12%5.44M-3.98%4.59M-60.44%16.13M-70.90%3.54M-63.32%3.66M
Gross profit -10.77%9.62M-23.35%9.19M-6.57%45.83M-7.22%10.25M23.60%12.81M-26.14%10.79M-8.08%11.99M-26.38%49.05M-40.47%11.05M-18.69%10.36M
Operating expense 3.85%11.59M-11.88%10.69M-10.71%43.29M-15.76%9.61M-11.35%10.39M-2.56%11.16M-12.76%12.13M-38.59%48.49M-27.56%11.41M-46.84%11.71M
Selling and administrative expenses 13.86%11.07M-4.99%10.25M-8.93%38.29M-10.30%8.48M-8.64%9.3M-2.96%9.72M-12.93%10.78M-40.01%42.04M-32.95%9.45M-49.04%10.18M
-Selling and marketing expense 13.77%6M-5.96%5.32M-5.33%20.91M-11.82%4.78M-2.95%5.19M1.03%5.27M-7.09%5.66M-46.72%22.08M-32.07%5.42M-58.20%5.35M
-General and administrative expense 13.96%5.07M-3.92%4.92M-12.90%17.38M-8.24%3.7M-14.95%4.11M-7.31%4.45M-18.59%5.13M-30.30%19.95M-34.11%4.03M-32.69%4.83M
Research and development costs --0--0-52.11%1.33M-79.27%216K-73.49%162K0.19%522K-28.40%426K-32.38%2.77M124.09%1.04M-28.62%611K
Depreciation amortization depletion -42.89%526K-51.79%444K0.00%3.68M0.00%921K0.00%920K0.33%921K-0.32%921K-23.08%3.68M-22.93%921K-23.21%920K
-Depreciation and amortization -42.89%526K-51.79%444K0.00%3.68M0.00%921K0.00%920K0.33%921K-0.32%921K-23.08%3.68M-22.93%921K-23.21%920K
Operating profit -421.16%-1.97M-930.14%-1.5M349.03%2.54M277.29%640K278.94%2.42M-112.02%-378K83.16%-146K104.58%565K-112.85%-361K85.44%-1.35M
Net non-operating interest income expense 48.10%-560K48.09%-516K26.80%-3.7M41.74%-730K28.40%-900K14.77%-1.08M22.53%-994K-1.93%-5.06M-1.25M-1.26M
Non-operating interest expense -48.10%560K-48.09%516K-26.80%3.7M-41.74%730K-28.40%900K-14.77%1.08M-22.53%994K1.93%5.06M--1.25M--1.26M
Other net income (expense) -537.96%-8.05M51.06%3.99M-113.78%-12.58M-1,996.75%-19.35M172.48%2.3M482.33%1.84M149.56%2.64M-2,541.49%-5.88M-204.62%-923K-59.70%843K
Gain on sale of security -373.34%-8.24M31.39%3.78M57.47%-1.7M-773.96%-9.86M122.32%2.26M622.70%3.02M148.76%2.88M-183.54%-4M206.48%1.46M-60.47%1.02M
Special income (charges) --0--0-276.87%-10.36M-229.73%-8.26M--0---1.32M---784K41.93%-2.75M5.08%-2.51M-133.24%-244K
-Less:Restructuring and merger&acquisition --0--0-2.55%2.1M--0--0--1.32M--784K322.50%2.16M511.18%1.91M133.24%244K
-Less:Impairment of capital assets --------------------------------------0
-Less:Other special charges ------------------------------594K--------
-Write off ----------8.26M------------------0--------
Other non- operating income (expenses) 35.71%190K-62.92%201K-158.85%-512K-1,125.00%-1.23M-48.57%36K45.83%140K-7.19%542K372.83%870K-96.77%120K105.76%70K
Income before tax -2,870.68%-10.58M31.17%1.97M-32.44%-13.75M-666.38%-19.44M316.07%3.82M-72.69%382K120.05%1.5M39.14%-10.38M-3.26%-2.54M75.46%-1.77M
Income tax 00-79.60%437K-48.04%437K-123.42%-122K-136.28%-283K405K2.14M841K521K
Net income -1,443.15%-10.58M33.31%1.97M14.40%-13.56M-329.24%-19.82M238.34%3.99M458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M
Net income continuous Operations -1,691.58%-10.58M79.78%1.97M-13.27%-14.18M-488.51%-19.88M272.20%3.94M7.43%665K114.63%1.09M26.57%-12.52M-37.48%-3.38M68.22%-2.29M
Net income discontinuous operations --0--0118.65%620K105.00%62K109.02%54K114.66%123K158.89%381K---3.32M---1.24M---599K
Minority interest income
Net income attributable to the parent company -1,443.15%-10.58M33.31%1.97M14.40%-13.56M-329.24%-19.82M238.34%3.99M458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,443.15%-10.58M33.31%1.97M14.40%-13.56M-329.24%-19.82M238.34%3.99M458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M
Basic earnings per share -907.69%-1.05-12.50%0.2124.48%-2.16-287.80%-3.18225.00%0.65425.00%0.13116.22%0.2444.03%-2.86-38.98%-0.8273.06%-0.52
Diluted earnings per share -303.85%-1.0546.67%-0.0824.48%-2.16-287.80%-3.18140.38%0.21-550.00%-0.2689.86%-0.1544.03%-2.86-38.98%-0.8273.06%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More